Answers are grounded in this paper and cite their sources.
A hyperactive immune response is the driving force behind severe Coronavirus disease 2019 (COVID-19). Complications of severe COVID-19 include acute respiratory distress syndrome, acute respiratory failure, and increased risk of venous thromboembolism (VTE). The management of patients with COVID-19 includes respiratory support, decreasing immune response to the virus to prevent the progression of disease, and anticoagulation to prevent VTE.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: